Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
ImmunoGen: Turning Around In A Coronavirus Environment
02:03pm, Tuesday, 25'th Aug 2020
ImmunoGen is a turnaround stock that has tremendous potential. After temporary regulatory and clinical setbacks, the company is on a vigorous campaign for a change.
Jazz Pharma (JAZZ) Beats on Q2 Earnings & Sales, Raises View
04:10pm, Wednesday, 05'th Aug 2020
Jazz Pharmaceuticals (JAZZ) reports better-than-expected second-quarter 2020 earnings and revenues. It raises its guidance for 2020. Shares rise.
What's Behind Jazz Pharmaceuticals' Q2 Revenue and Earnings Beats
10:38am, Wednesday, 05'th Aug 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) hasn't given investors much good news so far in 2020. The drugmaker's first-quarter results announced in May were disappointing. Jazz stock has dropped 23% year to
Jazz Pharmaceuticals (JAZZ) Q2 Earnings and Revenues Beat Estimates
10:45pm, Tuesday, 04'th Aug 2020
Jazz (JAZZ) delivered earnings and revenue surprises of 9.76% and 11.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals Announces Second Quarter 2020 Financial Results
08:05pm, Tuesday, 04'th Aug 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2020 and updated its 2020 financial guidance.
Preview: Jazz Pharmaceuticals's Earnings
04:12pm, Monday, 03'rd Aug 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) announces its next round of earnings this Tuesday, August 04. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.Earnings
Harmony Biosciences Starts U.S. IPO Effort
12:23pm, Friday, 31'st Jul 2020
Harmony Biosciences has filed to raise $100 million in an IPO, although the final figure will likely differ.
10 Biggest Biotechnology Companies
11:32pm, Thursday, 30'th Jul 2020
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Jul 2020
Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jazz Pharmaceuticals Wins FDA Approval for Its New Narcolepsy Drug
05:49pm, Wednesday, 22'nd Jul 2020
Xywav has been shown to reduce both cataplexy and excessive daytime sleepiness in narcolepsy patients.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Insiders Increased Their Holdings
12:45pm, Wednesday, 22'nd Jul 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution on July 21
Jazz Pharmaceuticals to Report 2020 Second Quarter Financial Results on August 4, 2020
08:05pm, Tuesday, 21'st Jul 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 second quarter financial results on Tuesday, August 4, 2020, after the close of the financial markets. Company mana
Assessing An Investment In Avadel Pharmaceuticals
12:51pm, Thursday, 16'th Jul 2020
Today, we take an in-depth look at Avadel Pharmaceuticals which recently sold off its existing product portfolio.
National Comprehensive Cancer Network® adds Zepzelca™ (lurbinectedin) to Clinical Practice Guidelines in Oncology
12:00pm, Monday, 13'th Jul 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Zepzelca™ (lurbinectedin) was added by the National Comprehensive Cancer Network (NCCN®) to the Clinical Practice Guidelines in Oncology
